Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype
nonalcoholic steatohepatitis (NASH), have emerged as significant contributors to hepatic …

Prediction of hepatocellular carcinoma (HCC) risk is an urgent unmet need in patients with
nonalcoholic fatty liver disease (NAFLD). In cohorts of 409 patients with NAFLD from …

Patients with nonalcoholic fatty liver disease (NAFLD) continue to increase with the
epidemics of obesity, and NAFLD is estimated to become the most prevalent etiology of …

Liver fibrosis is the result of sustained chronic liver injury and inflammation leading to
hepatocyte cell death followed by the formation of fibrous scars, which is the hallmark of …

The rising prevalence of liver diseases related to obesity and excessive use of alcohol is
fuelling an increasing demand for accurate biomarkers aimed at community screening …

The severity of fibrosis is central to the therapeutic course for patients with chronic liver
disease; therefore, early detection of liver fibrosis is critical for timely therapeutic …

Purpose Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease, with a
worldwide prevalence of 25%. Although numerous clinical trials have been conducted over …

Liver cancer, mainly hepatocellular carcinoma (HCC), remains a major cause of cancer-
related death worldwide. With the global epidemic of obesity, the major HCC etiologies have …

Metabolic dysfunction-associated steatotic liver disease (MASLD), defined by the presence
of liver steatosis together with at least one out of five cardiometabolic factors, is the most …

Spatial transcriptomics, leveraging sequencing-and imaging-based techniques, has
emerged as a groundbreaking technology for mapping gene expression within the complex …